- Home
- VERO vs INM Comparison
VERO vs INM Comparison
Compare VERO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- INM
- Stock Information
- Founded
- VERO N/A
- INM 1981
- Country
- VERO Canada
- INM Canada
- Employees
- VERO N/A
- INM N/A
- Industry
- VERO Medical/Dental Instruments
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- VERO Health Care
- INM Health Care
- Exchange
- VERO Nasdaq
- INM Nasdaq
- Market Cap
- VERO 2.4M
- INM 2.3M
- IPO Year
- VERO N/A
- INM N/A
- Fundamental
- Price
- VERO $0.31
- INM $3.12
- Analyst Decision
- VERO
- INM
- Analyst Count
- VERO 0
- INM 0
- Target Price
- VERO N/A
- INM N/A
- AVG Volume (30 Days)
- VERO 128.1K
- INM 84.1K
- Earning Date
- VERO 03-31-2025
- INM 02-12-2025
- Dividend Yield
- VERO N/A
- INM N/A
- EPS Growth
- VERO N/A
- INM N/A
- EPS
- VERO N/A
- INM N/A
- Revenue
- VERO $67,200,000.00
- INM $4,832,013.00
- Revenue This Year
- VERO N/A
- INM N/A
- Revenue Next Year
- VERO $4.95
- INM N/A
- P/E Ratio
- VERO N/A
- INM N/A
- Revenue Growth
- VERO N/A
- INM N/A
- 52 Week Low
- VERO $0.28
- INM $2.42
- 52 Week High
- VERO $1.59
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- VERO 38.70
- INM 37.82
- Support Level
- VERO $0.30
- INM $3.03
- Resistance Level
- VERO $0.32
- INM $3.48
- Average True Range (ATR)
- VERO 0.02
- INM 0.20
- MACD
- VERO -0.00
- INM 0.05
- Stochastic Oscillator
- VERO 12.62
- INM 35.59
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.